Overall, the NUF2-HMGA2 axis was identified as a novel interaction regulating tumorigenesis and progression in ccRCC, and thus can be an ideal therapeutic target and a promising prognostic indicator for ccRCC. Here, NUF2 is linked to nonpapillary renal cell carcinoma.